A new study reveals that tolcapone, a dopamine-enhancing drug, strengthens brain circuits involved in self-control while reducing alcohol intake in people with alcohol use disorder (AUD). The drug boosts activity in the inferior frontal gyrus, part of the prefrontal cortex, which supports inhibitory control.